To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer — Stella

Recruiting

Back to Stomach Neoplasms trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

China

The First Hospital of China Medical University, Shenyang, Liaoning

The First Hospital of China Medical University, Shenyang, Liaoning

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

SUNHO（China）BioPharmaceutical CO., Ltd.

Enrollment target

~90 participants

Started

August 2024

Primary completion

July 2026

Age range

18 Years – 75 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov